Tuesday 30 April 2024

Medical Tourism Market By MOHW Hengchun Tourism Hospital; Apollo Hospitals Enterprise Ltd.; Bumrungrad International Hospital

 


The global Medical Tourism Market size is expected to reach USD 75.3 billion by 2030, growing at a CAGR of 25.22% from 2023 to 2030, according to a new report by Grand View Research, Inc. Cardiovascular treatment (coronary artery bypass graft and heart valve transplantation), dental treatment (veneers, implants, and crowns), cosmetic treatment (breast implants and facelifts) and orthopedic treatment (knee & hip reconstruction and spinal surgery), are among the most frequently performed procedures for medical tourists.

Most elective surgeries, such as cosmetic surgery, certain dental surgeries, fertility treatments, and weight loss surgeries, are not covered by insurance companies in the U.S. Limited availability or lack of insurance coverage drives people to seek procedures in countries such as Thailand, India, and Malaysia. Cosmetic surgeries in most countries are considered elective, and therefore, are not covered under health insurance. This results in interested patients seeking treatment options abroad.

Patients can save treatment costs substantially by traveling to countries where such services are provided at lower costs. For instance, according to the American Society of Plastic Surgeons, a breast augmentation procedure average costs around USD 4,500 to USD 5,000 for an individual in the U.S., compared to around USD 3,000 to USD 4,000 in Malaysia. In addition, the cost of IVF treatment in the U.S. is between USD 12,000 and USD 25,000, whereas in Thailand, it is priced at around USD 6,200 and USD 12,000. This price difference has led to an increase in patient arrivals in Asian countries.

Moreover, the option of combining wellness and medical trips with outstanding clinical facilities and traditional medicine therapies is driving many patients to prefer this option. China has emerged as a key destination for travelers seeking stem cell therapies. Stem cell research is banned in several countries. However, it is legal in China and hence tourists consider China for undergoing it legally. The China market is growing rapidly, owing to a globally expanding middle class, an aging population, and an increasing demand for cosmetic surgery.

Advertising is critical in gaining new clients. Similar to many other privately driven sectors, medical tourism requires advertising exposure. Advertising on websites has become the primary source of information for health travelers. Therefore, having more recognized hospitals enhances a country's global standing. The phenomenal increase in health tourism is being accompanied by the establishment of Joint Commission International (JCI)-accredited health centers.

Singapore, for example, has numerous specialist clinics and 22 hospitals, and specialized centers accredited by the JCI, all of which provide high-quality healthcare services. Due to the availability of state-of-the-art facilities, the country is an attractive medical tourism destination in terms of accommodation and housing alternatives.

However, the COVID-19 pandemic adversely impacted the market for medical tourism. It shook the travel and tourism industry to its foundations. Prominent hospital service providers suffered heavy losses in 2020, as COVID-19 pandemic travel restrictions negatively affected health services aimed at medical tourists. A majority of the workforce in this sector suffered economic losses. A sharp decline in the number of patient arrivals due to travel bans and strict regulations heavily impacted the overall market.

Related Press Release@ Medical Tourism Market Report

Medical Tourism Market Report Highlights

  • Based on treatment, the cosmetic segment held the largest revenue share of 23.9% in 2022. On the other hand, the infertility treatment segment is expected to record the fastest CAGR from 2023 to 2030
  • In terms of services providers, the private segment dominated the market, and it is likely to continue its dominance with the projected fastest CAGR of 25.86% from 2023 to 2030, owing to the growing number of public hospitals and focused on marketing strategies to attract foreign patients
  • Turkey was one of the notable markets in terms of revenue in 2022, owing to the high quality of health services and a high number of patient arrivals in the country
  • The Thailand medical tourism industry is anticipated to grow at a significant CAGR of 27.8% from 2023 to 2030. Popular destinations in Thailand are Bangkok, Phuket, Pattaya, Chiang Moi, Samui, and Hua Hin
  • Singapore is also among the major medical tourism destination on the global stage. The country is ranked second in the Medical Tourism Index by the Medical Tourism Association, behind Canada. Singapore's private hospitals provide superior healthcare services with highly trained specialists and state-of-the-art infrastructure
  • Singapore, Colombia, Taiwan, and Spain are among the leading destinations with the highest growth rates. Medical tourism is a significant source of revenue for several countries. They have a sophisticated healthcare infrastructure and a qualified workforce that enables them to serve foreign patients
  • Thailand is a popular destination for cosmetic procedures, while India is the preferred destination for cardiothoracic and orthopedic procedures. Dental operations are favored in Brazil and Costa Rica

Medical Tourism Market Report Scope

Report Attribute

Details

Market size value in 2023

USD 15.6 billion

Revenue forecast in 2030

USD 75.3 billion

Growth rate

CAGR of 25.2% from 2023 to 2030

Base year for estimation

2022

Historical data

2018 - 2021

Forecast period

2023 - 2030

 

Request For A Free Consultation@ https://www.grandviewresearch.com/request-free-consultation/1119/rfc

Medical Tourism Market Segmentation

Grand View Research has segmented the global medical tourism market based on treatment type, service provider, and country:

Medical Tourism Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Cardiovascular Treatment
  • Orthopedic Treatment
  • Cosmetic Treatment
  • Bariatric Treatment
  • Dental Treatment
  • Ophthalmology Treatment
  • Infertility Treatment
  • Alternative Medicine
  • Other Services

Medical Tourism Service Provider Outlook (Revenue, USD Million, 2018 - 2030)

  • Public
  • Private

Medical Tourism Country Outlook (Revenue, USD Million, 2018 - 2030)

  • Thailand
  • India
  • Costa Rica
  • Mexico
  • Malaysia
  • Singapore
  • Brazil
  • Colombia
  • Turkey
  • Taiwan
  • South Korea
  • Czech Republic
  • Spain
  • China
  • Australia
  • Indonesia

 

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

U.S. Revenue Cycle Management Market Worth $308.2 Billion By 2030


The U.S. Revenue Cycle Management Market size is expected to reach USD 308.2 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.3% from 2023 to 2030. Growing data siloes emerging from multiple healthcare functionalities and departments are driving the need to consolidate and streamline unorganized workflows to boost efficiency and productivity in healthcare organizations. Furthermore, the growing trend of digital health and widespread adoption of healthcare IT solutions are anticipated to accelerate market growth. The market growth in the U.S. can also be attributed to the increasing healthcare IT spending and the growing trend of outsourcing RCM systems and services.

Healthcare systems in the U.S. are undergoing significant transformations and readily adopting electronic processes for claims and reimbursement management. The presence of numerous renowned healthcare facilities, increasing healthcare awareness and spending, and the growing digital literacy are expected to support the growth of the market. Favorable regulatory reforms from government agencies and regular technological advancements by market players are expected to boost market growth over the forthcoming years. The growing need for regular technological advancements is driving market players to revise their product development strategies to improve provider-patient relationship in healthcare facilities. Key participants are focusing on collaborations and strategic partnerships with other market players to combine expertise and grow their business footprint.

For instance, in January 2020, R1 RCM, Inc. entered into a strategic partnership with Rush University System for Health (RUSH) to achieve revenue cycle performance excellence and boost innovation in healthcare. As per the agreement, the platform by R1 RCM would be integrated with RUSH’s Epic EMR workflow, which uses enterprise-wide performance analytics and intelligent automation to improve the company’s current revenue cycle operations. In addition, the collaboration would aid R1 RCM to launch its innovation lab, which focuses on value-based care and incorporates advanced analytics to educate other healthcare institutions in preparing for the future healthcare workforce. This partnership is expected to enable significant improvements in serving patients and financial results in the Chicago metropolitan area.

Market players are introducing innovative product solutions to expand their product portfolio and grow their clientele. For instance, in June 2019, Homecare Homebase (HCHB) introduced a new RCM tool that would reduce the burden related to staffing and time-consuming administrative functions, which often restrict the home health agencies from spending more quality time with patients. Moreover, this new tool offers greater transparency into the murky RCM process that is suitable for agency management, by making use of HCHB dashboards and analytical systems. This new tool makes use of extensive knowledge of the billing process, which aids in achieving and maintaining high collection days and reducing outstanding days in accounts receivable (AR), enabling more time with patients.

List of Key Players of U.S. Revenue Cycle Management Market

  • The SSI Group, Inc.
  • AllScripts Healthcare, LLC
  • eClinicalWorks
  • McKesson Corporation
  • athenahealth, Inc.
  • Epic Systems Corporation
  • NXGN Management, LLC
  • Oncospark, Inc.

Related Press Release@ U.S. Revenue Cycle Management Market Report

U.S. Revenue Cycle Management Market Report Highlights

  • The services component segment dominated the market in 2022 owing to the outsourcing of RCM services from third-party vendors with adequate skill set and workforce
  • By product type, integrated system spearheaded the market in 2022 owing to the growing demand from healthcare organizations for a synchronized single platform to manage financial activities
  • The web-based delivery mode segment dominated the market in 2022 owing to the cost-effectiveness and rapid deployment associated with these solutions
  • The hospitals end-user segment led the market in 2022 owing to the presence of well-established hospitals and growing healthcare IT infrastructure
  • The others physician specialty segment dominated the market in 2022 owing to the increase in insurance coverage policies for other healthcare services
  • The in-house sourcing segment held the largest revenue share in 2022 owing to the advantages offered such as patient information confidentiality and entire control of coding operations
  • Based on function, the claims management segment led the market in 2022 owing to the increasing patient volume and the presence of ineffective claim management systems

U.S. Revenue Cycle Management Market Report Scope

Report Attribute

Details

The market size value in 2023

USD 155.6 billion

The revenue forecast in 2030

USD 308.2 billion

Growth Rate

CAGR of 10.3% from 2023 to 2030

The base year for estimation

2022

Historical data

2017 - 2021

Forecast period

2023 - 2030

 

Request For A Free Consultation@ https://www.grandviewresearch.com/request-free-consultation/5647/rfc

U.S. Revenue Cycle Management Market Segmentation

Grand View Research, Inc. has segmented the U.S. revenue cycle management market on the basis of end user, product type, component, delivery mode, physician specialty, sourcing, and function:

U.S. Revenue Cycle Management End-user Outlook (Revenue, USD Billion, 2016 - 2030)

  • Hospitals
  • Physician & Clinical Services

U.S. Revenue Cycle Management Product Type Outlook (Revenue, USD Billion, 2016 - 2030)

  • Integrated System
  • Standalone System

U.S. Revenue Cycle Management Component Outlook (Revenue, USD Billion, 2016 - 2030)

  • Software Solution
  • Services

U.S. Revenue Cycle Management Delivery Mode Outlook (Revenue, USD Billion, 2016 - 2030)

  • On-premise
  • Web-based
  • Cloud-based

U.S. Revenue Cycle Management Physician Specialty Outlook (Revenue, USD Billion, 2016 - 2030)

  • Oncology
  • Cardiology
  • Anesthesia
  • Radiology
  • Pathology
  • Pain Management
  • Emergency Service
  • Others

U.S. Revenue Cycle Management Sourcing Outlook (Revenue, USD Billion, 2016 - 2030)

  • In-house
  • External RCM Apps/ Software
  • Outsourced RCM Services

U.S. Revenue Cycle Management Function Outlook (Revenue, USD Billion, 2016 - 2030)

  • Product Development
  • Member Engagement
  • Network Management
  • Care Management
  • Claim Management
  • Risk and Compliances

About Us:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Thursday 25 April 2024

Digital Pathology Market Size To Reach $1.73 Billion By 2030


The global Digital Pathology Market size is expected to reach USD 1.73 billion by 2030, registering a CAGR of 8.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness exponential growth owing to rising prevalence of chronic diseases aided by increasing demand for accurate diagnostics. Chronic diseases affect nearly one in every three adults. Whereas, according to the CDC, in the U.S., approximately, 51.8% of adults have at least one chronic disease. Digital pathology, including molecular tissue profiling, biobanking, tissue microarray analysis, and molecular biology, plays an important role in the drug development pipeline and companion diagnostics. Growing demand for high-quality tissue samples in tissue-based biomarker research is expected to drive technology adoption over the forecast period.

Increasing adoption of telepathology with the launch of newer versions of the technology, such as in June 2022, Tribun Health launched TeleSlide Patho 5, an online telepathology platform used for providing clinical and timely expertise to patients. Moreover, the market is expected to see intense competition in the near future as companies adopt more stringent strategies to compete. Moreover, technological advancements, such as the digitization of pathology lab makes the specialty more efficient, the specimen more reproducible, and pathologists' work easier. In past few years, several breakthrough advancements have provided a significant boost to market growth.

For instance, in September 2021, Paige received FDA approval for Paige Prostate, an AI solution for the detection of prostate cancer. The product is the first AI-enabled pathology product to gain marketing authorization. This was further followed by the collaboration of F. Hoffmann-La Roche Ltd. with Ibex in October 2021 for the development of artificial intelligence-based pathology applications for the improvement of patient care. Furthermore, major players are adopting strategies like collaborations and partnerships with a focus on technological advancements, such as robotic light microscopy, digital imaging, multiple fiber optic communications, and computerization, to enhance the adoption of digital pathology.

For instance, in December 2022, Deciphex launched Patholytix 3.0, a Digital Research Pathology Platform with an aim to revolutionize tools available for research pathologists and designed to overcome the limits of LIMS software that allows users to effectively manage associated data and samples. Furthermore, with the launch, the company also highlighted features of the new platform that impact workflow and offer simpler and more expedient report creation.

List of Key Players in the Digital Pathology Market

  • Leica Biosystems Nussloch GmbH (Danaher)
  • Hamamatsu Photonics, Inc.
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • F. Hoffmann-La Roche Ltd.
  • Mikroscan Technologies, Inc.
  • Inspirata, Inc.
  • Epredia (3DHISTECH Ltd.)
  • Visiopharm A/S
  • Huron Technologies International Inc.
  • ContextVision AB
  • CellaVision
  • HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO)
  • West Medica Produktions- und Handels- GmbH (West Medica)
  • aetherAI
  • IBEX (IBEX MEDICAL ANALYTICS)
  • SigTuple Technologies Private Limited
  • Morphle Labs, Inc
  • Bionovation Biotech, Inc.

Related Press Release@ Digital Pathology Market Report

Digital Pathology Market Report Highlights

  • Based on product, The device segment held the largest share of 51.72% in 2023 and is anticipated to grow at a lucrative growth rate during the projected period. The device segment includes a slide management system and scanner. The segment growth is attributed to the increasing adoption of digital pathology in academic research activities with enhanced resolution
  • Based on application, Disease diagnosis is anticipated to witness the fastest growth rate from 2024 to 2030 due to an increasing prevalence of chronic diseases and demand for noble diagnosis techniques
  • In terms of end-use, The hospitals segment dominated the market in 2023 with a share of 36.7% due to the growing incorporation of digital pathologies in healthcare settings for efficient disease diagnosis
  • North America dominated overall market in 2023 with a share of 40.7%, due to the presence of well-established digital infrastructure and several technological advancements pertaining to the incorporation of technology in healthcare settings

Request For A Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/1397/rfc

Digital Pathology Market Segmentation

Grand View Research has segmented the global digital pathology market based on product, type, application, end-use, and region:

Digital Pathology Product Outlook (Revenue, USD Billion, 2018 - 2030)

  • Software
  • Device
    • Scanners
    • Slide Management System
  • Storage System

Digital Pathology Type Outlook (Revenue, USD Billion, 2018 - 2030)

  • Human Pathology
  • Veterinary Pathology

Digital Pathology Application Outlook (Revenue, USD Billion, 2018 - 2030)

  • Drug Discovery & Development
  • Academic Research
  • Disease Diagnosis
    • Cancer Cell Detection
    • Others

Digital Pathology End-use Outlook (Revenue, USD Billion, 2018 - 2030)

  • Hospitals
  • Biotech & Pharma Companies
  • Diagnostic Labs
  • Academic & Research Institutes

Digital Pathology Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
    • ROE
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • RoLATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-95196
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Wednesday 24 April 2024

Legal Marijuana Market Size To Reach $102.2 Billion By 2030

 


The global Legal Marijuana Market size is expected to reach USD 102.24 billion by 2030, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 25.7% from 2024 to 2030. Increase in rate of legalization of marijuana for medicinal and adult-use/recreational marijuana, growing adoption of these products for the treatment of chronic ailments and rise in a number of new product launches are the primary factors responsible for the growth of the market. For instance, in March 2023, Irwin Naturals Inc., a herbal supplement formulator, introduced company's’ new CBD 25mg Softgels in Canada. It is available through the Starseed Medicinal Medical Group platform across the nation.

In April 2022, New Jersey legalized recreational and medical marijuana, and it is being sold at 13 facilities. This move has made New Jersey one of the 18 states in the United States where recreational marijuana is legal. The market is experiencing growth due to the widespread acceptance of cannabis and its high demand. Since its legalization, the use of marijuana in medical treatments has increased, leading to a decrease in the illegal trade of cannabis. According to a study conducted by New York University, the usage of cannabis among individuals aged 50-64 has doubled in the last decade and has now reached 9.0%.

Moreover, price of legal marijuana is lower than medical marijuana, and taxes would be levied on marijuana products after its legalization. Therefore, cultivators are focusing on cultivating marijuana in areas that are exempt from taxes. For instance, in New York, marijuana cultivators are focusing on tribal regions to get exempted from the taxes levied by the government. This is expected to lower the overall cost of cultivation of marijuana in the state, and cultivators can sell marijuana at lower prices. Lower prices of marijuana are further anticipated to boost the adoption of marijuana in the market.

List of Key Players of Legal Marijuana Market

  • Canopy Growth Corporation
  • AURORA CANNABIS INC.
  • Tilray Brands Inc. (Aphria, Inc.)
  • ABcann Medicinals, Inc. (VIVO Cannabis Inc.)
  • The Cronos Group
  • MARICANN INC.
  • Organigram Holdings Inc.
  • Lexaria Bioscience
  • GW Pharmaceuticals (Jazz Pharmaceuticals, Inc.)
  • Tikun Olam
  • United Cannabis Corporation

Related Press Release@ Legal Marijuana Market Report

Legal Marijuana Market Report Highlights

  • By application, medical segment accounted for the largest revenue share of 79.1% in 2023 owing to the high demand among healthcare practitioners and patients for medicinal marijuana.
  • By product type, oil and tinctures held the largest market share in 2023 owing to low price and ease of accessibility of flowers compared to other products.
  • In 2023, North America dominated the overall market with a revenue share of 76.0% owing to its large consumer base, North America was among the first regions to legalize the use of medical and recreational cannabis. 

Legal Marijuana Market Report Scope

Report Attribute

Details

Market size value in 2024

USD 26.0 billion

Revenue forecast in 2030

USD 102.2 billion

Growth rate

CAGR of 25.7% from 2024 to 2030

Actual data

2018 - 2023

Forecast data

2024 - 2030

 

Request For A Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/5051/rfc

Legal Marijuana Market Report Segmentation

Grand View Research has segmented the global legal marijuana market on the basis of application, product type, and region:

Legal Marijuana Application Outlook (Revenue, USD Billion, 2018 - 2030)

  • Medical
    • Chronic Pain
    • Cancer
    • Depression and Anxiety
    • Arthritis
    • Diabetes
    • Glaucoma
    • Migraines
    • Epilepsy
    • Multiple Sclerosis
    • AIDS
    • Amyotrophic Lateral Sclerosis
    • Alzheimer’s
    • Post-traumatic Stress Disorder (PTSD)
    • Parkinson's
    • Tourette’s
    • Others
  • Adult Use

Legal Marijuana Product Type Outlook (Revenue, USD Billion, 2018 - 2030)

  • Flower
  • Oil & Tinctures

Legal Marijuana Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Italy
    • Netherlands
    • Croatia
    • Poland
    • Czech Republic
    • Switzerland
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
    • New Zealand
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Uruguay
    • Colombia
  • Middle East and Africa (MEA)
    • South Africa
    • Israel

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Medical Tourism Market By MOHW Hengchun Tourism Hospital; Apollo Hospitals Enterprise Ltd.; Bumrungrad International Hospital

  The global  Medical Tourism Market  size is expected to reach USD 75.3 billion by 2030, growing at a CAGR of 25.22% from 2023 to 2030, acc...